Do you want to read an article? Please log in or register.
Impact of glucose on risk of dementia: Mendelian randomisation studies in 115,875 individuals
Further Publications
COMMENTED
Related content
Diabetes - GeneralType 2 Diabetes
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study.
Lancet Diabetes Endocrinol.
Schmidt AF et al.
doi: 10.1016/S2213-
Diabetes - GeneralType 2 Diabetes
Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study
Diabetologia.
Lu CH, Yang CY, Li CY, Hsieh CY, Ou HT
doi: 10.1007/
COMMENTED
Type 2 Diabetes
Is Type 2 Diabetes Mellitus Causally Associated with Cancer Risk? Evidence From a Two-Sample Mendelian Randomisation Study
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
doi: 10.2337/db20-0084.
Diabetes - GeneralType 2 DiabetesGlycemic Control
Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation
Diabetes Care.
Herman WH, Pan Q, Edelstein SL, Mather KJ, Perreault L, Barrett-Connor E, Dabelea DM, Horton E, Kahn SE, Knowler WC, Lorenzo C, Pi-Sunyer X, Venditti E, Ye W; Diabetes Prevention Program Research Group
doi: 10.2337/dc17-1116.
Type 1 Diabetes
Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study
Diabetologia.
Steineck IIK, Ranjan A, Schmidt S, Clausen TR, Holst JJ, Nørgaard K
doi: 10.1007/s00125-018-4807-8.
Diabetes - GeneralType 2 DiabetesObesity and Bariatric Surgery
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
Lancet.
le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DC, Van Gaal L, Ortiz RV, Wilding JP, Skjøth TV, Manning LS, Pi-Sunyer X; SCALE Obesity Prediabetes NN8022-1839 Study Group
doi: 10.1016/
COMMENTED
Type 2 Diabetes
IGF-1 and cardiometabolic diseases: a Mendelian randomisation study
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetologia.
Larsson SC, Michaëlsson K, Burgess S
doi: 10.1007/s00125-020-05190-9.
Type 2 DiabetesGlycemic Control
Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
Lancet Diabetes Endocrinol.
Zoungas S, Arima H, Gerstein HC, Holman RR, Woodward M, Reaven P, Hayward RA, Craven T, Coleman RL, Chalmers J; Collaborators on Trials of Lowering Glucose (CONTROL) group
doi: 10.1016/S2213-8587(17)
Diabetes - GeneralType 2 Diabetes
Dementia onset, incidence and risk in type 2 diabetes: a matched cohort study with the Fremantle Diabetes Study Phase I
Diabetologia.
Davis WA, Zilkens RR, Starkstein SE, Davis TM, Bruce DG
doi: 10.1007/s00125-016-4127-9.